• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[16S rDNA测序在呼吸机相关性肺炎患者痰液物种多样性分析中的应用]

[The use of 16S rDNA sequencing in species diversity analysis for sputum of patients with ventilator-associated pneumonia].

作者信息

Yang Xiaojun, Wang Xiaohong, Liang Zhijuan, Zhang Xiaoya, Wang Yanbo, Wang Zhenhai

机构信息

Department of Critical Care Medicine, General Hospital of Ningxia Medical University, Yinchun 750004, Ningxia, China. Corresponding author: Yang Xiaojun, Email:

出版信息

Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2014 May;26(5):294-9. doi: 10.3760/cma.j.issn.2095-4352.2014.05.002.

DOI:10.3760/cma.j.issn.2095-4352.2014.05.002
PMID:24809255
Abstract

OBJECTIVE

To study the species and amount of bacteria in sputum of patients with ventilator-associated pneumonia (VAP) by using 16S rDNA sequencing analysis, and to explore the new method for etiologic diagnosis of VAP.

METHODS

Bronchoalveolar lavage sputum samples were collected from 31 patients with VAP. Bacterial DNA of the samples were extracted and identified by polymerase chain reaction (PCR). At the same time, sputum specimens were processed for routine bacterial culture. The high flux sequencing experiment was conducted on PCR positive samples with 16S rDNA macro genome sequencing technology, and sequencing results were analyzed using bioinformatics, then the results between the sequencing and bacteria culture were compared.

RESULTS

(1) 550 bp of specific DNA sequences were amplified in sputum specimens from 27 cases of the 31 patients with VAP, and they were used for sequencing analysis. 103 856 sequences were obtained from those sputum specimens using 16S rDNA sequencing, yielding approximately 39 Mb of raw data. Tag sequencing was able to inform genus level in all 27 samples. (2) Alpha-diversity analysis showed that sputum samples of patients with VAP had significantly higher variability and richness in bacterial species (Shannon index values 1.20, Simpson index values 0.48). Rarefaction curve analysis showed that there were more species that were not detected by sequencing from some VAP sputum samples. (3) Analysis of 27 sputum samples with VAP by using 16S rDNA sequences yielded four phyla: namely Acitinobacteria, Bacteroidetes, Firmicutes, Proteobacteria. With genus as a classification, it was found that the dominant species included Streptococcus 88.9% (24/27), Limnohabitans 77.8% (21/27), Acinetobacter 70.4% (19/27), Sphingomonas 63.0% (17/27), Prevotella 63.0% (17/27), Klebsiella 55.6% (15/27), Pseudomonas 55.6% (15/27), Aquabacterium 55.6% (15/27), and Corynebacterium 55.6% (15/27). (4) Pyrophosphate sequencing discovered that Prevotella, Limnohabitans, Aquabacterium, Sphingomonas might not be detected by routine bacteria culture. Among seven species which were identified by both methods, pyrophosphate sequencing yielded higher positive rate than that of ordinary bacteria culture [Streptococcus: 88.9% (24/27) vs. 18.5% (5/27), Klebsiella: 55.6% (15/27) vs. 18.5% (5/27), Acinetobacter: 70.4% (19/27) vs. 37.0% (10/27), Corynebacterium: 55.6% (15/27) vs. 7.4% (2/27), P<0.05 or P<0.01]. Sequencing positive rate was found to increase positive rate for culture of Pseudomonas [55.6% (15/27) vs. 25.9% (7/27), P=0.050]. No significant differences were observed between sequencing and ordinary bacteria culture for detection Staphylococcus [7.4% (2/27) vs. 11.1% (3/27)] and Neisseria bacteria genera [18.5% (5/27) vs. 3.7% (1/27), both P>0.05].

CONCLUSIONS

16S rDNA sequencing analysis confirmed that pathogenic bacteria in sputum of VAP were complicated with multiple drug resistant strains. Compared with routine bacterial culture, pyrophosphate sequencing had higher positive rate in detecting pathogens. 16S rDNA gene sequencing technology may become a new method for etiological diagnosis of VAP.

摘要

目的

采用16S rDNA测序分析研究呼吸机相关性肺炎(VAP)患者痰液中的细菌种类及数量,探索VAP病因诊断的新方法。

方法

收集31例VAP患者的支气管肺泡灌洗痰液样本。采用聚合酶链反应(PCR)提取并鉴定样本的细菌DNA。同时,对痰液标本进行常规细菌培养。对PCR阳性样本采用16S rDNA宏基因组测序技术进行高通量测序实验,运用生物信息学分析测序结果,然后比较测序与细菌培养结果。

结果

(1)31例VAP患者中27例的痰液标本扩增出550 bp的特异性DNA序列,用于测序分析。采用16S rDNA测序从这些痰液标本中获得103 856条序列,产生约39 Mb的原始数据。标签测序能够在所有27个样本中鉴定到属水平。(2)α多样性分析显示,VAP患者的痰液样本细菌种类具有显著更高的变异性和丰富度(香农指数值为1.20,辛普森指数值为0.48)曲线分析显示,一些VAP痰液样本中存在更多未被测序检测到的菌种。(3)采用16S rDNA序列分析27例VAP痰液样本,得到四个菌门:即放线菌门、拟杆菌门、厚壁菌门、变形菌门。以属为分类标准,发现优势菌种包括链球菌88.9%(24/27)、栖湖菌77.8%(21/27)、不动杆菌70.4%(19/27)、鞘氨醇单胞菌63.0%(17/27)、普雷沃菌63.0%(1 /27)、克雷伯菌55.6%(15/27)、假单胞菌55.6%(15/27)、水生杆菌55.6%(15/27)和棒状杆菌55.6%(15/27)。(4)焦磷酸测序发现,普雷沃菌、栖湖菌、水生杆菌、鞘氨醇单胞菌可能未被常规细菌培养检测到。在两种方法均鉴定出的7个菌种中,焦磷酸测序的阳性率高于普通细菌培养[链球菌:88.9%(24/27)比18.5%(5/27),克雷伯菌:55.6%(15/27)比18.5%(5/27),不动杆菌:70.4%(19/27)比37.0%(10/27),棒状杆菌:55.6%(15/27)比7.4%(2/27),P<0.05或P< O.01]。测序阳性率提高了假单胞菌培养的阳性率[55.6%((15/27)比25.9%(7/27),P=0.050]。在检测葡萄球菌[7.4%(2/27)比11.1%(3/27)]和奈瑟菌属[18.5%(5/27)比3.7%(1/27),P均>0.05]方面,测序与普通细菌培养之间未观察到显著差异。

结论

16S rDNA测序分析证实VAP患者痰液中的病原菌复杂且多为耐药菌株。与常规细菌培养相比,焦磷酸测序在检测病原体方面具有更高的阳性率。16S rDNA基因测序技术可能成为VAP病因诊断的新方法。

相似文献

1
[The use of 16S rDNA sequencing in species diversity analysis for sputum of patients with ventilator-associated pneumonia].[16S rDNA测序在呼吸机相关性肺炎患者痰液物种多样性分析中的应用]
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2014 May;26(5):294-9. doi: 10.3760/cma.j.issn.2095-4352.2014.05.002.
2
High-throughput sequencing of 16S rDNA amplicons characterizes bacterial composition in bronchoalveolar lavage fluid in patients with ventilator-associated pneumonia.16S rDNA扩增子的高通量测序可表征呼吸机相关性肺炎患者支气管肺泡灌洗 fluid中的细菌组成。 (注:原文中“bronchoalveolar lavage fluid”少了个单词“样本”之类的,推测是漏了,翻译时按完整意思“支气管肺泡灌洗样本”来理解了,若有更准确原文可进一步完善)
Drug Des Devel Ther. 2015 Aug 18;9:4883-96. doi: 10.2147/DDDT.S87634. eCollection 2015.
3
[Diversity analysis of biofilm bacteria on tracheal tubes removed from intubated neonates].[对从气管插管新生儿身上取下的气管导管上生物膜细菌的多样性分析]
Zhonghua Er Ke Za Zhi. 2013 Aug;51(8):602-6.
4
16S rDNA-based identification of bacteria from conjunctival swabs by PCR and DGGE fingerprinting.通过聚合酶链反应(PCR)和变性梯度凝胶电泳(DGGE)指纹图谱技术,基于16S核糖体DNA(rDNA)对结膜拭子中的细菌进行鉴定。
Invest Ophthalmol Vis Sci. 2001 May;42(6):1164-71.
5
16S rRNA gene sequencing is a non-culture method of defining the specific bacterial etiology of ventilator-associated pneumonia.16S核糖体RNA基因测序是一种用于确定呼吸机相关性肺炎特定细菌病因的非培养方法。
Int J Clin Exp Med. 2015 Oct 15;8(10):18560-70. eCollection 2015.
6
Increased constituent ratios of Klebsiella sp., Acinetobacter sp., and Streptococcus sp. and a decrease in microflora diversity may be indicators of ventilator-associated pneumonia: a prospective study in the respiratory tracts of neonates.丰度增加的克雷伯菌属、不动杆菌属和链球菌属以及微生物多样性减少可能是呼吸机相关性肺炎的指标:一项对新生儿呼吸道的前瞻性研究。
PLoS One. 2014 Feb 20;9(2):e87504. doi: 10.1371/journal.pone.0087504. eCollection 2014.
7
Employment of broad range 16S rDNA PCR and sequencing in the detection of aetiological agents of meningitis.应用广谱16S rDNA聚合酶链反应和测序技术检测脑膜炎的病原体。
New Microbiol. 2005 Apr;28(2):135-43.
8
Then and now: use of 16S rDNA gene sequencing for bacterial identification and discovery of novel bacteria in clinical microbiology laboratories.过去与现在:16S rDNA基因测序在临床微生物实验室细菌鉴定及新细菌发现中的应用
Clin Microbiol Infect. 2008 Oct;14(10):908-34. doi: 10.1111/j.1469-0691.2008.02070.x.
9
16S rDNA PCR-DGGE and sequencing in the diagnosis of neonatal late-onset septicemia.16S rDNA聚合酶链反应-变性梯度凝胶电泳及测序在新生儿晚发型败血症诊断中的应用
Mol Med Rep. 2015 Oct;12(4):6346-52. doi: 10.3892/mmr.2015.4131. Epub 2015 Jul 28.
10
Direct detection of bacterial pathogens in brain abscesses by polymerase chain reaction amplification and sequencing of partial 16S ribosomal deoxyribonucleic acid fragments.通过聚合酶链反应扩增和部分16S核糖体脱氧核糖核酸片段测序直接检测脑脓肿中的细菌病原体。
Neurosurgery. 2004 Nov;55(5):1154-62. doi: 10.1227/01.neu.0000140842.37422.ee.

引用本文的文献

1
Draft Genome Sequence of the Versatile Alkane-Degrading Bacterium Aquabacterium sp. Strain NJ1.多功能烷烃降解细菌水生杆菌属菌株NJ1的基因组序列草图
Genome Announc. 2014 Dec 4;2(6):e01271-14. doi: 10.1128/genomeA.01271-14.